• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁共振成像(MRI)在评估局部晚期乳腺癌新辅助化疗肿瘤反应中的有效性

The validity of MRI in evaluation of tumor response to neoadjuvant chemotherapy in locally advanced breast cancer.

作者信息

Abedi Mahboobeh, Farrokh Donya, Shandiz Homaei Fatemeh, Joulaee Azadeh, Anbiaee Robab, Zandi Behrooz, Gity Masoumeh, Sayah Hamid Reza, Abedi Mohammad Sadegh

机构信息

Dept. of Radiology, Imam Reza Hospital, Mashad University of Medical Sciences, Mashad, Iran.

Solid Tumor Treatment Research Center, Mashad University of Medical Sciences, Mashad, Iran.

出版信息

Iran J Cancer Prev. 2013 Winter;6(1):28-35.

PMID:25250107
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4142902/
Abstract

BACKGROUND

Physical Examination (PE) and breast MRI are two of the currentmethods which have usually used in diagnosis of primary breast cancer. Their accuracy in detection of: either complete response or presence of residual tumor, however, has not yet been established in patients who have been received Neoadjuvant Chemotherapy (NAC).The purpose of this study was to evaluate the diagnostic accuracy of breast MRI in assessment of residual neoplastic tissue after NAC in patients with Locally Advanced Breast Cancer (LABC).

METHODS

Twenty patients with LABC have undergone contrast-enhanced MRI before and after the NAC. Considering histology as the gold standard, the tumor sizes in MRI and PE have compared with the histology results. We have calculated for all below: the accuracy, sensitivity, specificity, Positive Predictive Value (PPV) and Negative Predictive Value (NPV) for each of MRI and physical examination, as well as Pearson's correlation coefficients between the results of MRI and PE, and their histology results.

RESULTS

We have found an accuracy of 85% for MRI with a sensitivity of 100%, a specificity of 50%, a PPV of 83.3%, and an NPV of 100%. In addition, theaccuracy for PE was 70% with a sensitivity of 71.4%, a specificity of 66.6%, a PPV of 83.3%, and an NPV of 50%. In this study, the calculated Pearson's correlation coefficient for MRI and histology was 0.817 (p<0.0001) versus 0.26 (p=0.26) for correlation between PE and histology.

CONCLUSION

MRI has higher sensitivity but less specificity than PE for detection of residual tumor after NAC in locally advanced breast carcinoma. Also, the tumor size that has measured by MRI had highly correlation with the histology.

摘要

背景

体格检查(PE)和乳腺MRI是目前常用于原发性乳腺癌诊断的两种方法。然而,对于接受新辅助化疗(NAC)的患者,它们在检测完全缓解或残留肿瘤方面的准确性尚未得到证实。本研究的目的是评估乳腺MRI在评估局部晚期乳腺癌(LABC)患者接受NAC后残留肿瘤组织的诊断准确性。

方法

20例LABC患者在NAC前后接受了对比增强MRI检查。以组织学为金标准,将MRI和PE中的肿瘤大小与组织学结果进行比较。我们计算了以下各项:MRI和体格检查各自的准确性、敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV),以及MRI和PE结果与它们的组织学结果之间的Pearson相关系数。

结果

我们发现MRI的准确性为85%,敏感性为100%,特异性为50%,PPV为83.3%,NPV为100%。此外,PE的准确性为70%,敏感性为71.4%,特异性为66.6%,PPV为83.3%,NPV为50%。在本研究中计算得出,MRI与组织学之间的Pearson相关系数为0.817(p<0.0001),而PE与组织学之间的相关系数为0.26(p=0.26)。

结论

在检测局部晚期乳腺癌NAC后的残留肿瘤方面,MRI的敏感性高于PE,但特异性低于PE。此外,MRI测量的肿瘤大小与组织学高度相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f8f/4142902/619b1a9a2b68/IJCP-06-028f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f8f/4142902/b189a35a3a19/IJCP-06-028f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f8f/4142902/787dfd1a9002/IJCP-06-028f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f8f/4142902/62eaa615d622/IJCP-06-028f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f8f/4142902/90405323ae9f/IJCP-06-028f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f8f/4142902/619b1a9a2b68/IJCP-06-028f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f8f/4142902/b189a35a3a19/IJCP-06-028f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f8f/4142902/787dfd1a9002/IJCP-06-028f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f8f/4142902/62eaa615d622/IJCP-06-028f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f8f/4142902/90405323ae9f/IJCP-06-028f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f8f/4142902/619b1a9a2b68/IJCP-06-028f5.jpg

相似文献

1
The validity of MRI in evaluation of tumor response to neoadjuvant chemotherapy in locally advanced breast cancer.磁共振成像(MRI)在评估局部晚期乳腺癌新辅助化疗肿瘤反应中的有效性
Iran J Cancer Prev. 2013 Winter;6(1):28-35.
2
The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography.乳腺癌对新辅助化疗反应的评估:磁共振成像与18F-氟脱氧葡萄糖正电子发射断层扫描的比较
Acta Radiol. 2011 Feb 1;52(1):21-8. doi: 10.1258/ar.2010.100142.
3
The Role of MRI in Assessing Residual Breast Cancer After Neoadjuvant Chemotherapy.MRI 在新辅助化疗后评估残留乳腺癌中的作用。
Am Surg. 2024 Feb;90(2):238-244. doi: 10.1177/00031348231198108. Epub 2023 Aug 23.
4
Analysis of factors that influence the accuracy of magnetic resonance imaging for predicting response after neoadjuvant chemotherapy in locally advanced breast cancer.分析影响局部晚期乳腺癌新辅助化疗后磁共振成像预测疗效准确性的因素。
Ann Surg Oncol. 2013 Aug;20(8):2562-8. doi: 10.1245/s10434-013-2925-6. Epub 2013 Mar 6.
5
Diagnostic accuracy of MRI to evaluate tumour response and residual tumour size after neoadjuvant chemotherapy in breast cancer patients.MRI评估乳腺癌患者新辅助化疗后肿瘤反应及残余肿瘤大小的诊断准确性。
Radiol Oncol. 2016 Feb 16;50(1):73-9. doi: 10.1515/raon-2016-0007. eCollection 2016 Mar 1.
6
Usefulness of automated breast volume scanner (ABVS) for monitoring tumor response to neoadjuvant treatment in breast cancer patients: preliminary results.自动乳腺容积扫描仪(ABVS)在监测乳腺癌患者新辅助治疗肿瘤反应中的作用:初步结果。
Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):225-231. doi: 10.26355/eurrev_201901_16768.
7
Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).新辅助化疗后对比增强磁共振成像(CE-MRI)的放射学完全缓解(rCR)可预测无复发生存期,但不能预测病理完全缓解(pCR)。
Breast Cancer Res. 2019 Jan 31;21(1):19. doi: 10.1186/s13058-018-1091-y.
8
Evaluation of Neoadjuvant Chemotherapy Response with Dynamic Contrast Enhanced Breast Magnetic Resonance Imaging in Locally Advanced Invasive Breast Cancer.动态对比增强乳腺磁共振成像评估局部晚期浸润性乳腺癌新辅助化疗反应
J Breast Health. 2014 Apr 1;10(2):111-118. doi: 10.5152/tjbh.2014.2035. eCollection 2014 Apr.
9
Accuracy of Magnetic Resonance Imaging-Guided Biopsy to Verify Breast Cancer Pathologic Complete Response After Neoadjuvant Chemotherapy: A Nonrandomized Controlled Trial.磁共振成像引导下活检对新辅助化疗后乳腺癌病理完全缓解的准确性:一项非随机对照试验。
JAMA Netw Open. 2021 Jan 4;4(1):e2034045. doi: 10.1001/jamanetworkopen.2020.34045.
10
Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients.临床检查、数字乳腺 X 线摄影、超声和 MRI 对可手术乳腺癌患者新辅助化疗后病理肿瘤反应的判断准确性。
Ann Surg Oncol. 2011 Oct;18(11):3160-3. doi: 10.1245/s10434-011-1919-5. Epub 2011 Sep 27.

引用本文的文献

1
The Accuracy of Breast Cancer Diagnostic Tools.乳腺癌诊断工具的准确性。
Cureus. 2024 Jan 7;16(1):e51776. doi: 10.7759/cureus.51776. eCollection 2024 Jan.
2
Evaluation of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer.乳腺癌新辅助化疗疗效评价。
Drug Des Devel Ther. 2020 Jun 18;14:2423-2433. doi: 10.2147/DDDT.S253961. eCollection 2020.
3
Contrast-Enhanced Mammography (CEM) for Detecting Residual Disease after Neoadjuvant Chemotherapy: A Comparison with Breast Magnetic Resonance Imaging (MRI).

本文引用的文献

1
Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?扩散加权磁共振成像和增强磁共振成像能否准确评估和预测乳腺癌患者新辅助化疗的病理反应?
Breast Cancer Res Treat. 2012 Aug;135(1):17-28. doi: 10.1007/s10549-012-2033-5. Epub 2012 Apr 4.
2
Primary systemic therapy in breast cancer--an update for gynecologic oncologists.乳腺癌的一线全身治疗——妇科肿瘤学家的最新进展
Eur J Gynaecol Oncol. 2011;32(6):636-41.
3
MRI features of the complete histopathological response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
对比增强乳腺摄影术(CEM)用于检测新辅助化疗后残留疾病:与乳腺磁共振成像(MRI)的比较。
Biomed Res Int. 2018 Nov 8;2018:8531916. doi: 10.1155/2018/8531916. eCollection 2018.
4
Comparison of efficacy of neoadjuvant chemotherapy FEC 100 and Docetaxel 75 versus AC and Docetaxel in locally advanced breast cancer: a randomized clinical study.新辅助化疗FEC 100与多西他赛75对比AC与多西他赛治疗局部晚期乳腺癌的疗效:一项随机临床研究
Med Oncol. 2015 Dec;32(12):261. doi: 10.1007/s12032-015-0697-5. Epub 2015 Oct 31.
局部晚期直肠癌新辅助放化疗完全组织病理学缓解的 MRI 特征。
Clin Radiol. 2012 Jun;67(6):546-52. doi: 10.1016/j.crad.2011.11.004. Epub 2012 Jan 2.
4
Early prediction of the response of breast tumors to neoadjuvant chemotherapy using quantitative MRI and machine learning.使用定量磁共振成像和机器学习对乳腺肿瘤新辅助化疗反应进行早期预测
AMIA Annu Symp Proc. 2011;2011:868-77. Epub 2011 Oct 22.
5
Is 18F-FDG PET accurate to predict neoadjuvant therapy response in breast cancer? A meta-analysis.18F-FDG PET 预测乳腺癌新辅助治疗反应的准确性如何?一项荟萃分析。
Breast Cancer Res Treat. 2012 Jan;131(2):357-69. doi: 10.1007/s10549-011-1780-z. Epub 2011 Sep 30.
6
Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients.临床检查、数字乳腺 X 线摄影、超声和 MRI 对可手术乳腺癌患者新辅助化疗后病理肿瘤反应的判断准确性。
Ann Surg Oncol. 2011 Oct;18(11):3160-3. doi: 10.1245/s10434-011-1919-5. Epub 2011 Sep 27.
7
The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography.乳腺癌对新辅助化疗反应的评估:磁共振成像与18F-氟脱氧葡萄糖正电子发射断层扫描的比较
Acta Radiol. 2011 Feb 1;52(1):21-8. doi: 10.1258/ar.2010.100142.
8
Effectiveness of dynamic contrast-enhanced magnetic resonance imaging in evaluating clinical responses to neoadjuvant chemotherapy in breast cancer.动态对比增强磁共振成像在评估乳腺癌新辅助化疗临床反应中的有效性。
Chin Med J (Engl). 2011 Jan;124(2):194-8.
9
[Importance of mammography, sonography and MRI for surveillance of neoadjuvant chemotherapy for locally advanced breast cancer].[乳腺钼靶摄影、超声检查和磁共振成像在局部晚期乳腺癌新辅助化疗监测中的重要性]
Radiologe. 2010 Nov;50(11):1008-13. doi: 10.1007/s00117-010-2009-6.
10
Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer.原发大肿瘤及局部晚期乳腺癌化疗后 FDG-PET 评估肿瘤残留:常规影像学与临床检查
Br J Cancer. 2010 Jan 5;102(1):35-41. doi: 10.1038/sj.bjc.6605427. Epub 2009 Nov 17.